InvestorsHub Logo

lax20m

09/11/10 11:27 AM

#1762 RE: BTH #1761

That deal would make me ecstatic however I don't think its realistic. Thats would be quite a leap of faith for a drug who has nothing other than phase 1 under its belt. Dont' get me wrong I think things look good but that might be a little rich at this point. Now if the trial starts and we get a good result at the first interim results I think something like that deal you cited would be doable. I'd prefer to hold off partnering just a bit longer. Although I'd like to see a partner in the mid term

JJM760

09/11/10 11:42 AM

#1765 RE: BTH #1761

You are a real sunny day at the beach aren't you? If the news was bad, I think we would have gotten it yesterday.

biotech_researcher

09/12/10 7:13 AM

#1773 RE: BTH #1761

This, and positive Ridaforolimus news will make this a winner. We do not have to wait too much longer for Rida, which would propel the SP much higher than the '534 news, imho, as we would be closer in hvaving a real product....

intune

09/12/10 3:39 PM

#1788 RE: BTH #1761

BTH - Perhaps you might respond to this -

Reading over your last line, it reads "LOL - imagine if they said they were on 'hold' for '534 due to an adverse event...LOL"

What exactly is the funny part? Please explain.